CONMED Corporation
CNMD
$44.50
$1.082.49%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.35B | 1.33B | 1.32B | 1.31B | 1.29B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.35B | 1.33B | 1.32B | 1.31B | 1.29B |
| Cost of Revenue | 585.04M | 574.34M | 573.78M | 572.38M | 567.55M |
| Gross Profit | 762.44M | 751.91M | 742.22M | 734.63M | 720.56M |
| SG&A Expenses | 553.12M | 540.90M | 534.27M | 519.28M | 515.96M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.19B | 1.17B | 1.16B | 1.15B | 1.14B |
| Operating Income | 155.16M | 157.20M | 154.17M | 160.92M | 149.32M |
| Income Before Tax | 85.51M | 137.69M | 145.28M | 163.03M | 160.07M |
| Income Tax Expenses | 21.44M | 27.49M | 26.53M | 30.61M | 28.33M |
| Earnings from Continuing Operations | 64.07 | 110.20 | 118.75 | 132.42 | 131.74 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 64.07M | 110.20M | 118.75M | 132.42M | 131.74M |
| EBIT | 155.16M | 157.20M | 154.17M | 160.92M | 149.32M |
| EBITDA | 227.20M | 228.60M | 224.84M | 231.38M | 219.48M |
| EPS Basic | 2.07 | 3.57 | 3.85 | 4.29 | 4.28 |
| Normalized Basic EPS | 2.47 | 2.48 | 2.39 | 2.50 | 2.26 |
| EPS Diluted | 2.05 | 3.53 | 3.80 | 4.24 | 4.21 |
| Normalized Diluted EPS | 2.46 | 2.46 | 2.37 | 2.48 | 2.23 |
| Average Basic Shares Outstanding | 123.80M | 123.70M | 123.57M | 123.37M | 123.21M |
| Average Diluted Shares Outstanding | 124.40M | 124.46M | 124.52M | 124.64M | 124.99M |
| Dividend Per Share | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 |
| Payout Ratio | 38.60% | 22.42% | 20.78% | 18.62% | 18.69% |